{
    "Clinical Trial ID": "NCT00356148",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Prophylaxis Group",
        "  patients who are BMI over 25 and receiving ampicillin/sulbactam prophylaxis",
        "INTERVENTION 2: ",
        "  No Prophylaxis Group",
        "  Patients who are BMI over 25 and not receive antibiotic prophylaxis"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Women at any age with early stage breast cancer (stage I-II) and American Society of Anesthesiologists (ASA) score of I-II.",
        "Exclusion Criteria:",
        "  Ductal carcinoma in situ (DCIS; stage 0 cancer),",
        "  Advanced or distant metastatic stage,",
        "  Receiving any neoadjuvant therapy,",
        "  History of receiving any antibiotics within prior 3 months,",
        "  History of immunodeficiency,",
        "  Having a remote infection,",
        "  History of reaction to study antibiotics,",
        "  Denial of signing the consent form."
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Number of Patients With Body Mass Index (BMI) Over 25 Who Developed Surgical Site Infection (SSI) in Groups Who Received Antibiotic Prophylaxis (Prophylaxis Group) and no Prophylaxis (No Prophylaxis Group).",
        "  [Not Specified]",
        "  Time frame: 1 month",
        "Results 1: ",
        "  Arm/Group Title: Prophylaxis Group",
        "  Arm/Group Description: patients who are BMI over 25 and receiving ampicillin/sulbactam prophylaxis",
        "  Overall Number of Participants Analyzed: 187",
        "  Measure Type: Number",
        "  Unit of Measure: participants  9",
        "Results 2: ",
        "  Arm/Group Title: No Prophylaxis Group",
        "  Arm/Group Description: Patients who are BMI over 25 and not receive antibiotic prophylaxis",
        "  Overall Number of Participants Analyzed: 182",
        "  Measure Type: Number",
        "  Unit of Measure: participants  25"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/189 (0.00%)",
        "Adverse Events 2:",
        "  Total: 0/183 (0.00%)"
    ]
}